NCI Community Oncology Research Program Clinical Trials

Title Intervention NCT IDsort ascending Sponsor Status
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal... Biospecimen Collection, Laboratory Biomarker Analysis NCT04955808 National Cancer Institute (NCI) Recruiting
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor Cognitive Assessment, Memantine Hydrochloride, Placebo Administration NCT04939597 Children's Oncology Group Recruiting
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer... Megestrol Acetate, Olanzapine, Questionnaire Administration NCT04939090 Alliance for Clinical Trials in Oncology Recruiting
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States Electronic Health Record Review, Interview, Survey Administration NCT04928599 Children's Oncology Group Recruiting
Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy Exercise Intervention NCT04888988 University of Rochester NCORP Research Base Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors Biospecimen Collection, Questionnaire Administration NCT04871542 Southwest Oncology Group Recruiting
Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer... Behavioral Intervention, Quality-of-Life Assessment, Questionnaire Administration NCT04829539 University of Rochester NCORP Research Base Recruiting
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation... Memantine Hydrochloride, Neurocognitive Assessment, Stereotactic Radiosurgery, Whole-Brain Radiotherapy NCT04804644 NRG Oncology Recruiting
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of... Dasatinib plus Quercetin, Fisetin NCT04733534 St. Jude Children's Research Hospital Recruiting
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation Denosumab, Placebo, Quality-of-Life Assessment NCT04711109 Alliance for Clinical Trials in Oncology Recruiting

Pages